Xiamen Amoytop Biotech Co. Ltd Financials

Market Capitalization CN¥34.04 Billion as of Jan. 1, 2026

Valuations Metrics as of Jan. 3, 2026

Trailing PE	36.23
Forward PE	24.08
Price to Sales TTM	CN¥10.22
Price to Book MRQ	CN¥11.31
Enterprise to Revenue	9.98
Enterprise to EBITDA	30.27

Financial Reports as of Jun. 30, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-06-30
Profit Margin	28.11%
Operating Margin	29.94%
Return on Assets TTM	20.06%
Return on Equity TTM	35.63%

Income Statement

Revenue TTM	CN¥3,342,004,480
Revenue per Share TTM	CN¥8.22
Quarterly Revenue Growth	26.70%
Gross Profit TTM	CN¥3,102,934,528
EBITDA	CN¥1,044,170,575
Net Income to Common TTM	CN¥939,576,832
Diluted EPS TTM	CN¥2.31
Quarterly Earnings Growth YoY	-4.60%

Balance Sheet

Total Cash MRQ	CN¥825,519,936
Total Cash per Share MRQ	CN¥2.03
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	4.69
Current Ratio MRQ	3.84
Book Value per Share MRQ	CN¥7.40

Cash Flow

Operating Cash Flow TTM	CN¥609,736,320
Levered Free Cash Flow TTM	CN¥244,344,096

688278 Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding	406,800,000
Float Shares	170,294,616
Avg 10 Volume	1,337,610
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	61.15%
% Held by Institutions	15.67%

Stock Price Summary

Beta	-0.23
Fifty Two Week Low	CN¥67.96
Fifty Two Week High	CN¥93.52
Fifty Two Week Change	13.59%
Day 50 MA	CN¥78.86
Day 200 MA	CN¥78.37

Dividends and Splits

Forward Annual Dividend Rate	CN¥2.48
Forward Annual Dividend Yield	2.96%
Trailing Annual Dividend Rate	CN¥0.62
Trailing Annual Dividend Yield	0.74%
Payout Ratio	26.84%
Dividend Date
Ex Dividend Date	2025-05-09
Last Split Factor
Last Split Date